SCHEDULE 14A
                    Proxy Statement Pursuant to Section 14(a)
            of the Securities Exchange Act of 1934 (Amendment No. __)


Filed by the Registrant    [  ]

Filed by a Party other than the Registrant    [x]

Check the appropriate box:

[  ]     Preliminary Proxy Statement
[  ]     Confidential, for Use of the Commission Only
         (as permitted by Rule 14a-6(e)(2))
[  ]     Definitive Proxy Statement
[  ]     Definitive Additional Materials
[X]      Soliciting Material Pursuant to ss. 240.14a-12

                            Mylan Laboratories, Inc.

                (Name of Registrant as Specified In Its Charter)

                                 Carl C. Icahn,
                   Barberry Corp., Hopper Investments LLC and
                         High River Limited Partnership


    (Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (check the appropriate box):

[X] No fee required.

[ ] Fee computed on table below per Exchange Act Rule 14a-6(i)(4) and 0-11.

         1) Title of each class of securities to which transaction applies:



         2) Aggregate number of securities to which transaction applies:



         3) Per unit price or other  underlying  value of  transaction  computed
pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee
is calculated and state how it was determined):



         4) Proposed maximum aggregate value of transaction:



         5) Total fee paid:



[  ]     Fee paid previously with preliminary materials.

[ ] Check box if any part of the fee is offset as provided by Exchange  Act Rule
0-11(a)(2)  and  identify  the  filing  for  which the  offsetting  fee was paid
previously.  Identify the previous filing by registration  statement  number, or
the Form or Schedule and the date of its filing.

         1) Amount Previously Paid:



         2) Form, Schedule or Registration Statement No.:



         3) Filing Party:



         4) Date Filed:







         On June 14, 2005, Carl Icahn issued a press releases attached hereto as
Exhibit A.

SECURITY  HOLDERS ARE ADVISED TO READ THE PROXY  STATEMENT  AND OTHER  DOCUMENTS
RELATED TO  SOLICITATION  OF PROXIES BY MR.  ICAHN AND HIS  AFFILIATES  FROM THE
STOCKHOLDERS OF MYLAN  LABORATORIES  INC. FOR USE AT ITS ANNUAL MEETING (A) WHEN
AND IF THEY BECOME AVAILABLE,  BECAUSE THEY WILL CONTAIN IMPORTANT  INFORMATION,
INCLUDING   INFORMATION   RELATING  TO  THE   PARTICIPANTS  IN  ANY  SUCH  PROXY
SOLICITATION,  AND (B) WHEN AND IF COMPLETED, A DEFINITIVE PROXY STATEMENT AND A
FORM OF PROXY WHICH WILL BE MAILED TO  STOCKHOLDERS OF MYLAN  LABORATORIES  INC.
AND WILL BE AVAILABLE AT NO CHARGE AT THE SECURITIES  AND EXCHANGE  COMMISSION'S
WEBSITE  AT   HTTP://WWW.SEC.GOV.   INFORMATION   RELATING   TO  THE   POTENTIAL
PARTICIPANTS IN A POTENTIAL PROXY  SOLICITATION IS CONTAINED IN THE SCHEDULE 13D
FILED  BY MR.  ICAHN  AND  HIS  AFFILIATES  WITH  THE  SECURITIES  AND  EXCHANGE
COMMISSION  ON FEBRUARY 28, 2005 WITH RESPECT TO MYLAN  LABORATORIES  INC.  THAT
SCHEDULE 13D IS CURRENTLY  AVAILABLE AT NO CHARGE ON THE SECURITIES AND EXCHANGE
COMMISSION'S WEBSITE.







                                                                      EXHIBIT A

                              FOR IMMEDIATE RELEASE
              ICAHN RESPONDS TO ACTIONS OF MYLAN LABORATORIES, INC.

New York, New York, June 14, 2005
Contact:  Susan Gordon (212) 702-4309


We are pleased that Mylan has finally  announced  actions  attempting to enhance
shareholder value.  However, it is a sad commentary that Mylan needed the strong
prodding of its largest shareholder to take the actions that were announced this
morning.  Additionally,  it should be noted that Mylan's partial tender offer is
for the most part at a price below our acquisition proposal.


SECURITY  HOLDERS ARE ADVISED TO READ THE PROXY  STATEMENT  AND OTHER  DOCUMENTS
RELATED TO  SOLICITATION  OF PROXIES BY MR.  ICAHN AND HIS  AFFILIATES  FROM THE
STOCKHOLDERS OF MYLAN  LABORATORIES  INC. FOR USE AT ITS ANNUAL MEETING (A) WHEN
AND IF THEY BECOME AVAILABLE,  BECAUSE THEY WILL CONTAIN IMPORTANT  INFORMATION,
INCLUDING   INFORMATION   RELATING  TO  THE   PARTICIPANTS  IN  ANY  SUCH  PROXY
SOLICITATION,  AND (B) WHEN AND IF COMPLETED, A DEFINITIVE PROXY STATEMENT AND A
FORM OF PROXY WHICH WILL BE MAILED TO  STOCKHOLDERS OF MYLAN  LABORATORIES  INC.
AND WILL BE AVAILABLE AT NO CHARGE AT THE SECURITIES  AND EXCHANGE  COMMISSION'S
WEBSITE  AT   HTTP://WWW.SEC.GOV.   INFORMATION   RELATING   TO  THE   POTENTIAL
PARTICIPANTS IN A POTENTIAL PROXY  SOLICITATION IS CONTAINED IN THE SCHEDULE 13D
FILED  BY MR.  ICAHN  AND  HIS  AFFILIATES  WITH  THE  SECURITIES  AND  EXCHANGE
COMMISSION  ON FEBRUARY 28, 2005 WITH RESPECT TO MYLAN  LABORATORIES  INC.  THAT
SCHEDULE 13D IS CURRENTLY  AVAILABLE AT NO CHARGE ON THE SECURITIES AND EXCHANGE
COMMISSION'S WEBSITE.